(1R,3aS,3bS,10aR,10bS,11S,12aS)-1-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-10a,12a-dimethyl-7-{3-[(pyridin-3-ylmethyl)carbamoyl]-phenyl}-1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl 1,3-oxazole-4-carboxylate | 1246778-80-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (1R,3aS,3bS,10aR,10bS,11S,12aS)-1-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-10a,12a-dimethyl-7-{3-[(pyridin-3-ylmethyl)carbamoyl]-phenyl}-1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl 1,3-oxazole-4-carboxylate
• 英文别名: [(1S,2R,13S,14S,17R,18S,20S)-17-(fluoromethylsulfanylcarbonyl)-20-hydroxy-2,18-dimethyl-7-[3-(pyridin-3-ylmethylcarbamoyl)phenyl]-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl] 1,3-oxazole-4-carboxylate
• CAS: 1246778-80-2
• 化学式: C₃₉H₄₀FN₅O₆S
• 分子量: 725.841
• InChiKey: ROAATKMNWFZQSA-VDJVBZHBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  52
• 可旋转键数：
  10
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  175
• 氢给体数：
  2
• 氢受体数：
  11

文献信息

• NOVEL AMIDE COMPOUNDS
  申请人：Burkamp Frank

  公开号：US20100256104A1

  公开（公告）日：2010-10-07

  The present invention provides compounds of formula (I) wherein n, R 1 , R 2 , X 1 , X 2 , X 3 , X 4 , X 5 , R 3a , R 3b , R 4 , R 5 and R 6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了如下式（I）的化合物，其中n，R1，R2，X1，X2，X3，X4，X5，R3a，R3b，R4，R5和R6如规范中所定义，以及它们的制备方法，含有它们的药物组合物以及它们在治疗中的用途。
• Novel Amide Compounds
  申请人：ASTRAZENECA AB, INTELLECTUAL PROPERTY

  公开号：US20130237507A1

  公开（公告）日：2013-09-12

  The present invention provides compounds of formula (1) wherein n, R 1 , R 2 , X 1 , X 2 , X 3 , X 4 , X 5 , R 3a , R 3b , R 4 , R 5 and R 6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了式（1）的化合物，其中n，R1，R2，X1，X2，X3，X4，X5，R3a，R3b，R4，R5和R6如规范中所定义，以及它们的制备方法、含有它们的药物组成物以及它们在治疗中的应用。